Lacosamide 50 mg

DRUG2 trials

Sponsors

UCB Pharma SA, Kafrelsheikh University

Conditions

EpilepsyMigraine DisordersPartial Onset Seizures

Phase 3

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

CompletedNCT01710657

UCB Pharma SAEpilepsy, Partial Onset Seizures

Start: 2012-09-30End: 2014-08-31Updated: 2017-08-25

Lacosamide Versus Topiramate in Migraine

RecruitingNCT06243692

Kafrelsheikh UniversityMigraine Disorders

Start: 2024-02-01End: 2025-02-25Target: 600Updated: 2024-03-29

Related Papers

Lacosamide versus topiramate in episodic migraine: a randomized controlled double-blinded trial.

2025-12-09

Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial

Epilepsy Research2021-06-2924 citations

Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study.

2016-09-0135 citations